Clinical Epidemiology
Volume 12, 2020 - Issue
Open access
155
Views
3
CrossRef citations to date
0
Altmetric
Original Research
Evaluating the Effectiveness of an Additional Risk Minimization Measure to Reduce the Risk of Prescribing Mirabegron to Patients with Severe Uncontrolled Hypertension in Four European Countries
Edith M Heintjes1 PHARMO Institute for Drug Outcomes Research, Utrecht, the NetherlandsCorrespondence[email protected]
https://orcid.org/0000-0002-2617-3845View further author information
Irene D Bezemer1 PHARMO Institute for Drug Outcomes Research, Utrecht, the NetherlandsView further author information
, Daniel Prieto-Alhambra2 Idiap Jordi Gol Primary Care Research Institute and CIBERFes, Universitat Autonoma de Barcelona and Instituto de Salud Carlos III, Barcelona, Catalonia, Spain;3 Centre for Statistics in Medicine, NDORMS, University of Oxford, Oxford, England, UKView further author information
, Elisabeth Smits1 PHARMO Institute for Drug Outcomes Research, Utrecht, the NetherlandsView further author information
, Helen P Booth4 Clinical Practice Research Datalink (CPRD), London, UKView further author information
, Daniel Dedman4 Clinical Practice Research Datalink (CPRD), London, UK
https://orcid.org/0000-0002-3699-5391View further author information
Ying He3 Centre for Statistics in Medicine, NDORMS, University of Oxford, Oxford, England, UKView further author information
, Fabian Hoti5 Statfinn - EPID Research, Espoo, FinlandView further author information
, Minna Vehkala5 Statfinn - EPID Research, Espoo, FinlandView further author information
, Stefan de Vogel6 Astellas Pharma Europe B.V., Leiden, NetherlandsView further author information
, Noah Jamie Robinson6 Astellas Pharma Europe B.V., Leiden, NetherlandsView further author information
, Kwame Appenteng7 Astellas Pharma Global Development, Inc., Northbrook, IL, USAView further author information
& Fernie J A Penning-van Beest1 PHARMO Institute for Drug Outcomes Research, Utrecht, the NetherlandsView further author information
show all
Pages 423-433
|
Published online: 01 May 2020
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.